Search research articles
Contact Us
Filters
Showing results (51-60 of 64) with videos related to
Page
of 7
Sort By:
Annals of Surgery
|
September 26, 2007
Long-term results of prospective trial of surgery alone with selective use of radiation for patients with T1 extremity and trunk soft tissue sarcomas
Peter W T Pisters, Raphael E Pollock, Valerae O Lewis, et al.
Journal of Cancer
|
March 14, 2015
Association of Body Mass Index Changes during Neoadjuvant Chemotherapy with Pathologic Complete Response and Clinical Outcomes in Patients with Locally Advanced Breast Cancer
Takahiro Kogawa, Tamer M Fouad, Caimiao Wei, et al.
Scientific Reports
|
May 24, 2020
Differential functions of ERK1 and ERK2 in lung metastasis processes in triple-negative breast cancer
Maria Gagliardi, Mary Kathryn Pitner, Jihyun Park, et al.
Blood
|
August 31, 2012
Targeting the insulin-like growth factor-1 receptor to overcome bortezomib resistance in preclinical models of multiple myeloma
Deborah J Kuhn, Zuzana Berkova, Richard J Jones, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 31, 2017
Long-Term Prognostic Risk After Neoadjuvant Chemotherapy Associated With Residual Cancer Burden and Breast Cancer Subtype
W Fraser Symmans, Caimiao Wei, Rebekah Gould, et al.
Nature Medicine
|
May 31, 2025
Sasanlimab plus BCG in BCG-naive, high-risk non-muscle invasive bladder cancer: the randomized phase 3 CREST trial
Neal D Shore, Thomas B Powles, Jens Bedke, et al.
Future Oncology (London, England)
|
May 24, 2026
Sasanlimab taken together with Bacillus Calmette-Guérin (BCG) compared with BCG alone in people with high-risk non-muscle invasive bladder cancer: a plain language summary
Neal D Shore, Thomas B Powles, Jens Bedke, et al.
Urology
|
February 4, 2014
Female gender is associated with a worse survival after radical cystectomy for urothelial carcinoma of the bladder: a competing risk analysis
Jamie C Messer, Shahrokh F Shariat, Colin P Dinney, et al.
Nature Medicine
|
July 21, 2025
Author Correction: Sasanlimab plus BCG in BCG-naive, high-risk non-muscle invasive bladder cancer: the randomized phase 3 CREST trial
Neal D Shore, Thomas B Powles, Jens Bedke, et al.
Oncotarget
|
November 3, 2016
Clinical outcomes based on multigene profiling in metastatic breast cancer patients
Reva K Basho, Debora de Melo Gagliato, Naoto T Ueno, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 64) with videos related to
Sort By:
Page
of 7
Annals of Surgery
|
September 26, 2007
Long-term results of prospective trial of surgery alone with selective use of radiation for patients with T1 extremity and trunk soft tissue sarcomas
Peter W T Pisters, Raphael E Pollock, Valerae O Lewis, et al.
Journal of Cancer
|
March 14, 2015
Association of Body Mass Index Changes during Neoadjuvant Chemotherapy with Pathologic Complete Response and Clinical Outcomes in Patients with Locally Advanced Breast Cancer
Takahiro Kogawa, Tamer M Fouad, Caimiao Wei, et al.
Scientific Reports
|
May 24, 2020
Differential functions of ERK1 and ERK2 in lung metastasis processes in triple-negative breast cancer
Maria Gagliardi, Mary Kathryn Pitner, Jihyun Park, et al.
Blood
|
August 31, 2012
Targeting the insulin-like growth factor-1 receptor to overcome bortezomib resistance in preclinical models of multiple myeloma
Deborah J Kuhn, Zuzana Berkova, Richard J Jones, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 31, 2017
Long-Term Prognostic Risk After Neoadjuvant Chemotherapy Associated With Residual Cancer Burden and Breast Cancer Subtype
W Fraser Symmans, Caimiao Wei, Rebekah Gould, et al.
Nature Medicine
|
May 31, 2025
Sasanlimab plus BCG in BCG-naive, high-risk non-muscle invasive bladder cancer: the randomized phase 3 CREST trial
Neal D Shore, Thomas B Powles, Jens Bedke, et al.
Future Oncology (London, England)
|
May 24, 2026
Sasanlimab taken together with Bacillus Calmette-Guérin (BCG) compared with BCG alone in people with high-risk non-muscle invasive bladder cancer: a plain language summary
Neal D Shore, Thomas B Powles, Jens Bedke, et al.
Urology
|
February 4, 2014
Female gender is associated with a worse survival after radical cystectomy for urothelial carcinoma of the bladder: a competing risk analysis
Jamie C Messer, Shahrokh F Shariat, Colin P Dinney, et al.
Nature Medicine
|
July 21, 2025
Author Correction: Sasanlimab plus BCG in BCG-naive, high-risk non-muscle invasive bladder cancer: the randomized phase 3 CREST trial
Neal D Shore, Thomas B Powles, Jens Bedke, et al.
Oncotarget
|
November 3, 2016
Clinical outcomes based on multigene profiling in metastatic breast cancer patients
Reva K Basho, Debora de Melo Gagliato, Naoto T Ueno, et al.
Page
of 7